ZVSAW

ZyVersa Therapeutics, Inc. Warrants
ZVSAW

Overview Fund Activity
Delisted

ZVSAW was delisted on the 20th of December, 2022.

Back to rankings

14 hedge funds and large institutions have $2.07M invested in ZyVersa Therapeutics, Inc. Warrants in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+14
Holders Change %
–
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MP
Mangrove Partners
Connecticut
$1.49M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
$90K
3
RA
RiverPark Advisors
New York
$90K
4
CM
Cohanzick Management
New York
$90K
5
CCM
Context Capital Management
California
$65K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
MP
1
Mangrove Partners
Connecticut
$1.49M +$1.49M +149,350 New
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$90K +$90K +525,000 New
RA
3
RiverPark Advisors
New York
$90K +$90K +525,000 New
CM
4
Cohanzick Management
New York
$90K +$90K +525,000 New
CCM
5
Context Capital Management
California
$65K +$65K +375,000 New
MI
6
MMCAP International
Cayman Islands
$48K +$48K +277,500 New
SCC
7
Spring Creek Capital
Kansas
$45K +$45K +262,500 New
WAM
8
Wolverine Asset Management
Illinois
$40K +$40K +236,207 New
CH
9
CVI Holdings
Delaware
$32K +$32K +187,425 New
AA
10
AQR Arbitrage
Connecticut
$24K +$24K +138,981 New
WA
11
Whitebox Advisors
Minnesota
$23K +$23K +132,675 New
SCM
12
Saba Capital Management
New York
$15K +$15K +86,247 New
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$15K +$15K +87,499 New
FLC
14
Fifth Lane Capital
Texas
$6K +$6K +37,500 New